Bellevue Group Ag Immunocore Holdings PLC Put Options Transaction History
Bellevue Group Ag
- $4.39 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IMCR
# of Institutions
146Shares Held
45.1MCall Options Held
297KPut Options Held
1.17M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.07MShares$225 Million0.14% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$155 Million2.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.21MShares$134 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.77MShares$120 Million0.1% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$74 Million0.74% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.4B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...